Oncothyreon Inc.·4

Sep 28, 5:34 PM ET

Oncothyreon Inc. 4

4 · Oncothyreon Inc. · Filed Sep 28, 2015

Insider Transaction Report

Form 4
Period: 2015-09-24
Transactions
  • Award

    Restricted Share Unit (RSU)

    2015-09-24+14,24514,245 total
    Common Stock (14,245 underlying)
Footnotes (2)
  • [F1]Approximately 75% of each RSU represents a contingent right to receive approximately 0.75 share of the issuer's Common Stock upon vesting and approximately 25% represents a contingent right to receive cash upon vesting, which cash will be used to facilitate such holder's satisfaction of U.S. federal income tax obligations in connection with the vesting of the RSUs.
  • [F2]100% vests on the two-year anniversary of the Transaction Date, subject to acceleration under certain circumstances.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION